Expression of multidrug resistance-associated protein (MRP) in head and neck squamous cell carcinoma

Cancer Letters

Volumn 126, Issue 1, 1998, Pages 89-95

  Tsuzuki, Hideaki ^a   Fujieda, Shigeharu ^a   Sunaga, Hiroshi ^a   Sugimoto, Chizuru ^a   Tanaka, Nobuyuki ^a   Saito, Hitoshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

ATP assay; Chemosensitivity testing; Head and neck cancer; MRP; Prognosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; MULTIDRUG RESISTANCE PROTEIN; PEPLEOMYCIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMOSENSITIVITY; DRUG CYTOTOXICITY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 0345451637     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00540-5     Document Type: Article

References (26)

1. Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M.V., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
2. Zaman G.J.R., Flens M.J., van Leusden M.R., de Haas M., Mülder H.S., Lankelma J., Pinedo H.M., Scheper R.J., Baas F., Broxterman H.J., Borst P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA. 91:1994;8822-8826.
3. Nooter K., Westerman A.M., Flens M.J., Zaman G.J.R., Scheper R.J., van Wingerden K.E., Burger H., Oostrum R., Boersma T., Sonneveld P., Gratama J.W., Kok T., Eggermont A.M.M., Bosman F.T., Stoter G. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cancer Res. 1:1995;1301-1310.
4. Ota E., Abe Y., Oshika Y., Ozeki Y., Iwasaki M., Inoue H., Yamazaki H., Ueyama Y., Takagi K., Ogata T., Tamaoki N., Nakamura M. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br. J. Cancer. 72:1995;550-554.
5. Chuman Y., Sumizawa T., Takebayashi Y., Niwa K., Yamada K., Haraguchi M., Furukawa T., Akiyama S., Aikou T. Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas. Int. J. Cancer. 66:1996;274-279.
6. Kruh G.D., Gaughan K.T., Godwin A., Chan A. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J. Natl. Cancer Inst. 87:1995;1256-1258.
7. Filipits M., Suchomel R.W., Dekan G., Haider K., Valdimarsson G., Depisch D., Pirker R. MRP and MDR1 gene expression in primary breast carcinomas. Clin. Cancer Res. 2:1996;1231-1237.
8. Endo K., Maehara Y., Ichiyoshi Y., Kusumoto T., Sakaguchi Y., Ohno S., Sugimachi K. Multidrug resistance-associated protein expression in clinical gastric carcinoma. Cancer. 77(Suppl.):1996;1681-1687.
9. Tomonaga M., Oka M., Narasaki F., Fukuda M., Nakano R., Takatani H., Ikeda K., Terashi K., Matsuo I., Soda H., Cowan K.H., Kohno S. The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers. Jpn. J. Cancer Res. 87:1996;1263-1270.
10. Sugawara I., Masunaga A., Itoyama S., Sumizawa T., Akiyama S., Yamashita T. Expression of multidrug resistance-associated protein (MRP) in thyroid cancers. Cancer Lett. 95:1995;135-138.
11. Burger H., Nooter K., Sonneveld P., van Wingerden K.E., Zaman G.J.R., Stoter G. High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia. Br. J. Haematol. 88:1994;348-356.
12. Zhou D.C., Zittoun R., Marie J.P. Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia. 9:1995;1661-1666.
13. Kuss B.J., Deeley R.G., Cole S.P.C., Willman C.L., Kopecky K.J., Wolman S.R., Eyre H.J., Lane S.A., Nancarrow J.K., Whitmore S.A., Callen D.F. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet. 343:1994;1531-1534.
14. Clifford S.C., Neal D.E., Lunec J. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder. Br. J. Cancer. 73:1996;659-666.
15. Tsuzuki H., Saito H., Imamura Y., Noriki S., Fukuda M. Early progression stage of malignancy as revealed by immunohistochemical demonstration of DNA instability; II, otorhinolaryngeal border-line neoplastic lesions. Eur. J. Histochem. 38:1994;291-302.
16. Flens M.J., Izquierdo M.A., Scheffer G.L., Fritz J.M., Meijer C.J.L.M., Scheper R.J., Zaman G.J.R. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res. 54:1994;4557-4563.
17. Tasaki Y., Nakagawa M., Ogata J., Kiue A., Tanimura H., Kuwano M., Nomura Y. Reversal by a dihydropyridine derivative of non-P-glycoprotein-mediated multidrug resistance in etoposide-resistant human prostatic cancer cell line. J. Urol. 154:1995;1210-1216.
18. Fujieda S., Noda I., Saito H., Hoshino T., Yagita M. Swainsonine augments the cytotoxicity of human lymphokine-activated killer cells against autologous thyroid cancer cells. Arch. Otolaryngol. Head Neck Surg. 120:1994;389-394.
19. Fujieda S., Noda I., Saito H., Hoshino T., Yagita M. Heat shock enhances the susceptibility of tumor cells to lysis by lymphokine-activated killer cells. Arch. Otolaryngol. Head Neck Surg. 121:1995;1009-1014.
20. Garewal H.S., Ahmann F.R., Schifman R.B., Celniker A. ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects. J. Natl. Cancer Inst. 77:1986;1039-1045.
21. Tsuruo T., Iida-Saito H., Kawabata H., Oh-hara T., Hamada H., Utakoji T. Characteristics of resistance to Adriamycin in human myelogenous leukemia K562 resistant to Adriamycin and in isolated clones. Jpn. J. Cancer Res. 77:1986;682-692.
22. Simon S.M., Schindler M. Cell biological mechanisms of multidrug resistance in tumors. Proc. Natl. Acad. Sci. USA. 91:1994;3497-3504.
23. Giaccone G., Gazdar A.F., Beck H., Zunino F., Capranico G. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res. 52:1992;1666-1674.
24. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54:1994;4313-4320.
25. Fink D., Nebel S., Aebi S., Zheng H., Cenni B., Nehmé A., Christen R.D., Howell S.B. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 56:1996;4881-4886.
26. Kool M., de Haas M., Scheffer G.L., Scheper R.J., van Eijk M.J.T., Juijn J.A., Baas F., Borst P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:1997;3537-3547.